ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARa-SREBPs pathway

He, Jinbiao; Yang, Yu; Zhang, Fan; Li, Yanjuan; Li, Xiaosi; Pu, Xuemei; He, Xudong; Zhang, Mei; Yang, Xinxing; Yu, Qiuman; Qi, Yan*; Li, Xuefang*; Yu, Jie*云南大学; y
Frontiers in Pharmacology2022-10-5DOI: 10.3389/fphar.2022.1007274
7被引11阅读
引用收藏
分享

摘要

Despite the increase in the global prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD), no approved drug currently exists for the disease. Poria cocos (Schw.) Wolf (P. cocos) is a medicinal mushroom belonging to a family of polyporaceae widely used in TCM clinics to protect the liver and treat obesity. However, its efficacy, practical components, and underlying mechanism against MAFLD are yet to be determined. In this study, we evaluated the effects of Poria cocos (P. cocos) ethanol extract (EPC) on hepatic dyslipidemia, steatosis, and inflammation by both bioinformatics analysis and MAFLD rats induced by HFD feeding. We found EPC treatment dramatically reduced lipid accumulation, inflammatory cell infiltration, and liver injury. EPC reduced serum TC, TG levels, and hepatic TG, TBA, and NEFA contents. UHPLC Q-Trap/MS examination of BA profiles in serum and feces showed that EPC increased fecal conjugated BAs, decreased free BAs, and improved BA metabolism in HFD-fed rats. Western blot and RT-qPCR analysis showed that EPC could activate hepatic FXR and PPAR alpha expression and reduce CYP7A1 and SREBP-1c expression. Systemic pharmacology combined with molecular docking suggested that poricoic acid B and polyporenic acid C, the major active compounds in EPC, could ameliorate lipid homeostasis by activating the nuclear receptor PPAR alpha. We further confirmed their inhibition effects of lipid droplet deposition in steatized L-02 hepatocytes. In summary, EPC alleviated HFD-induced MAFLD by regulating lipid homeostasis and BA metabolism via the FXR/PPAR alpha-SREBPs signaling pathway. P. cocos triterpenes, such as poricoic acid B and polyporenic acid C, were the characteristic substances of P. cocos for the treatment of MAFLD.

学科与关键词

关键词
MAFLD (metabolic-associated fatty liver disease)Poria cocos (Schw) Wolfbile acid metabolismFXRP/PAR alpha-SREBP pathwaylipid homeostasisUPLC Q-TOF/MS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-10-05
卷期
第 13 卷
页码
1007274
DOI
10.3389/fphar.2022.1007274
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Application and Basis Research Project of Yunnan China; National Natural Science Foundation of China [2019IB009, 202002AA100007, 202001AZ070001-043, 202201AW070016, 2022Y345, 202105AG070012]; High-level TCM talents (reserve talents) project of Yunnan [82160748, 82104381]; [1]

作者

  • H

    He, Jinbiao (第一作者)

    yunnan univ

  • Y

    Yang, Yu

    yunnan univ

查看全部 13 位作者收起作者
  • Z

    Zhang, Fan

    yunnan univ

  • L

    Li, Yanjuan

    yunnan univ

  • L

    Li, Xiaosi

    yunnan univ

  • P

    Pu, Xuemei

    yunnan univ

  • H

    He, Xudong

    yunnan univ

  • Z

    Zhang, Mei

    yunnan univ

  • Y

    Yang, Xinxing

    yunnan univ

  • Y

    Yu, Qiuman

    yunnan univ

  • Q

    Qi, Yan (通讯)

    yunnan univ

  • L

    Li, Xuefang (通讯)

    yunnan univ

  • Y

    Yu, Jie (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417